Nonlinear pharmacokinetics of high-dose thiopental following long term treatment

Clinical Drug Investigation

Volumn 11, Issue 1, 1996, Pages 32-42

  Russo, Hélène ^a   Bressolle, Françoise ^b   Brès, Janine ^b   Duboin, Marie Paule ^a  

^a HÔPITAL SAINT ELOI   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THIOPENTAL;

ADOLESCENT; ADULT; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DATA ANALYSIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; ELECTROENCEPHALOGRAM; FEMALE; HEAD INJURY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRACRANIAL PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICHAELIS MENTEN KINETICS; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

EID: 0030070709     PISSN: 01142402     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199611010-00004     Document Type: Article

References (47)

1. Becker KE. Plasma levels of thiopental necessary for anesthesia. Anesthesiology 1978; 49: 192-6
2. Brand L, Mazzia VDB, Poznak AV, et al. Lack of correlation between electroencephelographic effects and plasma concentrations of thiopentone. Br J Anaesth 1961; 33: 92-6
3. Christensen JH, Andreasen F. Individual variation in response to thiopental. Acta Anaesthesiol Scand 1978; 22: 303-13
4. Cote CJ, Goridsouzian NG, Liu LMP, et al. The dose response of intravenous thiopental for the induction of general anesthesia in unpremedicated children. Anesthesiology 1981; 55: 703-5
5. Crankshaw DP, Edwards NE, Blackman GL, et al. Evaluation of infusion regimens for thiopentone as a primary anesthetic agent. Eur J Clin Pharmacol 1985; 28: 543-52
6. Dundee JW, Hassard TH, Mc Cowan WAW, et al. The induction dose of thiopentone. Anesthesia 1982; 37: 1176-84
7. Mark LC, Papper EM, Brodie BB, et al. Quantitative pharmacologic studies with pentothal. N Y State J Med 1949; 49: 1546-9
8. Heinemeyer G. Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure. Clin Pharmacokinet 1987; 13: 1-25
9. Marshall LF, Smith RW, Shapiro HM. The outcome with aggressive treatment in severe head injuries. Part II. Acute and chronic barbiturate administration in the management of head injury. J Neurosurg 1979; 50: 26-30
10. Michenfelder JD. The interdependency of cerebral functional and metabolic effects following massive doses of thiopental in the dog. Anesthesiology 1974; 41: 231-6
11. Roquefeuil B. Effets hémodynamiques et métaboliques des barbituriques sur le système nerveux central de l'homme. Ann Anesth Franç 1978; XIX (10): 807-14
12. Brown AS, Horton JM. Status epilepticus treated by intravenous infusions of thiopentone sodium. BMJ 1967; 1: 27-8
13. Cloyd JC, Wright BD, Perrier D. Pharmacokinetic properties of thiopental in two patients treated for uncontrolable seizures. Epilepsia 1979; 20: 313-8
14. Partinen M, Kovanen J, Nilsson E. Status epilepticus treated by barbiturate anaesthesia with continous monitoring of cerebral function. BMJ 1981; 282: 520-1
15. Airey IL, Smith PA, Stoddart JC. Plasma and cerebrospinal fluid barbiturate levels during prolonged continuous thiopentone infusion. Anaesthesia 1982; 37: 328-31
16. Le Corre P, Malledant Y, Tanguy M, et al. Non linear disposition of thiopentone following long-term infusion. Eur J Drug Metab Pharmacokinet 1993; 18 (3): 255-9
17. Stanski DR, Mihm FG, Rosenthal MH, et al. Pharmacokinetics of high-dose thiopental used in cerebral resuscitation. Anesthesiology 1980; 53 (2): 169-71
18. Taeger K, Murr R, Schmiedeck P, et al. Thiopentalkinetik bei hochdosierter Anwendung. Anästh. Intensivther. Notfallmed. 1986; 21: 237-44
19. Turcant A, Delhumeau A., Premel-Cabic A, et al. Thiopental pharmacokinetics under conditions of long-term infusion. Anesthesiology 1985; 63 (1): 50-4
20. Brodie BB, Mark LC, Papper EM, et al. The fate of thiopental in man and a method for its estimation in biological material. J Pharmacol Exp Ther 1950; 98: 85-96
21. Brodie BB. Physiological disposition and chemical fate of thiobartiturates in the body. Fed Proc 1952; 11: 632-9
22. Mark LC, Brand L, Kamvyssi S, et al. Thiopental metabolism by human liver in vivo and in vitro. Nature 1965; 206: 1117-9
23. Carroll FI, Smith D, Mark LC, et al. Determination of optically active thiopental thiamytal and their metabolites in human urine. Drug Metab Dispos 1977; 5 (4): 343-544
24. Mark LC. Metabolism of barbiturates in man. Clin Pharmacol Ther 1963; 4 (4): 504-30
25. Raventos J. The distribution in the body and metabolic fate of barbiturates. J Pharm Pharmacol 1954; 6: 217-35
26. Stanski DR, Burch PG, Harapat SH, et al. Pharmacokinetics and anesthetic potency of a thiopental isomer. J Pharm Sci 1983 Aug; 72 (8): 937-40
27. MicroPharm: Analyse des Données en Pharmacologie et Biologie, Version 4.0 Janvier 1995, Loginserm - Copyright 1990-1993 INSERM; par Urien S, Laboratoire de Pharmacologie, Faculté de Médecine, Université Paris XII, 8 rue du Général Sarrail, 94010 Créteil, France
28. Akaike A. An information criterion (AIC). Math Sci 1976; 14: 5-9
29. Statgraphics Plus For Windows. Version 1, Copyright 1994, Statistical Graphics Corporation and Manugistics, Inc.; with Unistat Plus for Windows, Logiciel d'Analyse des Données. Version 1.12, Copyright 1994-1995. 2115 East Jefferson Street Rockville, Maryland 20852 USA. Distributed by Uniware
30. Statgraphics Plus For Windows. Version 1, Copyright 1994, Statistical Graphics Corporation and Manugistics, Inc.; with Unistat Plus for Windows, Logiciel d'Analyse des Données. Version 1.12, Copyright 1994-1995. 2115 East Jefferson Street Rockville, Maryland 20852 USA. Distributed by Uniware
31. Andreasen F, Christensen JH, Jansen JAA. The individual variation in sensitivity and in pharmacokinetics of thiopentone in a group of young women. Proceedings of the BPS 1979; 399-400
32. Burch PG, Stanski DR. Decreased protein binding and thiopental kinetics. Clin Pharmacol Ther 1982; 32 (2): 212-7
33. Burch PG, Stanski DR. The role of metabolism and protein binding in thiopental anesthesia. Anesthesiology 1983; 58: 146-52
34. Christensen JH, Andreasen F, Jansen JA. Pharmacokinetics of thiopentone in a group of young women and a group of young men. Br J Anaesth 1980; 52 (9): 913-8
35. Christensen JH, Andreasen F, Jansen JA. Influence of age and sex on the pharmacokinetics of thiopentone. Br J Anaesth 1981; 53 (11): 1189-95
36. Christensen JH, Andreasen F, Jansen JA. Pharmacokinetics and pharmacodynamics of thiopentone : a comparison between young and elderly patients. Anaesthesia 1982; 37: 398-404
37. Christensen JH, Andreasen F, Jansen JA. Thiopentone sensitivity in young and elderly women. Br J Anaesth 1983; 55: 33-40
38. Christensen JH, Andreasen F, Jansen JA. Pharmacokinetics and pharmacodynamics of thiopental in patients undergoing renal transplantation. Acta Anaesth Scand 1983; 27: 513-8
39. Couderc E, Ferrier C, Haberer JP, et al. Thiopentone pharmacokinetics in patients with chronic alcoholism. Br J Anaesth 1984; 56: 1393-6
40. Ghoneim MM, Pandya HB. Plasma protein binding of thiopental in patients with impaired renal or hepatic function. Anesthesiology 1975; 42: 545-9
41. Ghoneim MM, Van Hamme MJ. Pharmacokinetics of thiopentone: effects of enflurane and nitrous oxide anaesthesia and surgery. Br J Anaesth 1978; 50: 1237-42
42. Homer TD, Stanski DR. The effect of increasing age on thiopental disposition and anesthetic requirement. Anesthesiology 1985; 62: 714-24
43. Jung D, Mayersohn M, Perrier D, et al. Thiopental disposition as a function of age in female patients undergoing surgery. Anesthesiology 1982; 56: 263-8
44. Morgan DJ, Blackman GL, Paull JD, et al. Pharmacokinetics and plasma binding of thiopental. 1. : Studies in surgical patients. Anesthesiology 1981; 54 (6): 468-73
45. Pandele G, Chaux F, Salvadori C, et al. Thiopental pharmacokinetics in patients with cirrhosis. Anesthesiology 1983; 59: 123-6
46. Russo H, Audran M, Bressolle F, et al. Displacement of thiopental from human serum albumin by associated drugs. J Pharm Sci 1993 May; 82 (5): 493-7
47. Russo H, Brès J, Duboin MP, et al. Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients. Eur J Clin Pharmacol 1995; 49 (7): 127-37